Abstract:
The management of chronic migraine (CM) underwent a significant shift with the introduction of onabotulinumtoxin A (BoNT-A) injections following the landmark PREEMPT trial in 2010. Despite its efficacy, the existing injection protocol lacks precision, prompting a call for revision in light of modern ultrasound (US)-guided techniques. This article highlights the potential of US-guided injections to enhance accuracy, safety, and efficacy in CM treatment. By providing real-time visualization and addressing anatomical variations, US guidance offers a promising avenue for optimizing BoNT-A delivery, minimizing adverse effects, and ensuring therapeutic success.
摘要:
在2010年具有里程碑意义的PREEMPT试验之后,慢性偏头痛(CM)的管理发生了重大转变,即引入了单乳毒素A(BoNT-A)注射。尽管它的功效,现有的注射方案缺乏精确性,促使人们呼吁根据现代超声(US)引导技术进行修订。这篇文章强调了美国指导注射提高准确性的潜力,安全,在CM治疗中的疗效。通过提供实时可视化和解决解剖变化,美国指南为优化BoNT-A交付提供了一个有希望的途径,尽量减少不利影响,并确保治疗成功。